Search Results Search Sort by RelevanceMost Recent Case and Commentary Mar 2021 印第安人非紧急护理卫生服务转诊能否得到公平分配? Hannah Wenger(医学博士) and Jo Henderson-Frost(医学博士) AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215. Case and Commentary Mar 2021 ¿Se pueden asignar equitativamente las derivaciones para atención no urgente del Servicio de Salud para Indígenas Estadounidenses? Hannah Wenger, MD and Jo Henderson-Frost, MD AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215. Case and Commentary Mar 2021 Can Indian Health Service Referrals for Nonemergent Care Be Allocated Equitably? Hannah Wenger, MD and Jo Henderson-Frost, MD Injustice is endemic to IHS operations when its stewards are forced to defer payment for patients’ nonemergent care. AMA J Ethics. 2021;23(3):E215-222. doi: 10.1001/amajethics.2021.215. AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Podcast Nov 2019 Ethics Talk: Quality of Life Assessments in Reconstructive Transplantation Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation. Podcast Nov 2022 Author Interview: “Necessity for and Limitations of Price Transparency in American Health Care” Dr Harold A. Pollack joins Ethics Talk to discuss his article: “Necessity for and Limitations of Price Transparency in American Health Care.” Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Jan 2015 Applying Guidelines to Individual Patients: Deep Brain Stimulation for Early-Stage Parkinson Disease, Commentary 1 Bryn Esplin, JD, Andre G. Machado, MD, PhD, and Paul J. Ford, PhD Surgery is appropriate when the needs and expected benefits outweigh the risks for a well-informed patient. Virtual Mentor. 2015;17(1):13-18. doi: 10.1001/virtualmentor.2015.17.1.ecas2-1501. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Mar 2021 印第安人非紧急护理卫生服务转诊能否得到公平分配? Hannah Wenger(医学博士) and Jo Henderson-Frost(医学博士) AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215.
Case and Commentary Mar 2021 ¿Se pueden asignar equitativamente las derivaciones para atención no urgente del Servicio de Salud para Indígenas Estadounidenses? Hannah Wenger, MD and Jo Henderson-Frost, MD AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215.
Case and Commentary Mar 2021 Can Indian Health Service Referrals for Nonemergent Care Be Allocated Equitably? Hannah Wenger, MD and Jo Henderson-Frost, MD Injustice is endemic to IHS operations when its stewards are forced to defer payment for patients’ nonemergent care. AMA J Ethics. 2021;23(3):E215-222. doi: 10.1001/amajethics.2021.215.
AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Podcast Nov 2019 Ethics Talk: Quality of Life Assessments in Reconstructive Transplantation Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.
Podcast Nov 2022 Author Interview: “Necessity for and Limitations of Price Transparency in American Health Care” Dr Harold A. Pollack joins Ethics Talk to discuss his article: “Necessity for and Limitations of Price Transparency in American Health Care.”
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Jan 2015 Applying Guidelines to Individual Patients: Deep Brain Stimulation for Early-Stage Parkinson Disease, Commentary 1 Bryn Esplin, JD, Andre G. Machado, MD, PhD, and Paul J. Ford, PhD Surgery is appropriate when the needs and expected benefits outweigh the risks for a well-informed patient. Virtual Mentor. 2015;17(1):13-18. doi: 10.1001/virtualmentor.2015.17.1.ecas2-1501.